Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
A phase 2 trial of Zamtocabtagene autoleucel, Rituximab, Gemcitabine in diffuse large b-cell lymphoma, run by Miltenyi Biomedicine GmbH, now recruiting.
Overview
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients is a phase 2 interventional study registered as NCT04844866 by Miltenyi Biomedicine GmbH, with 213 participants planned, started 2021-08-18 and due to reach its primary completion in 2025-01-15. Interventions recorded: MB-CART2019.1, Standard of Care. Conditions listed: Diffuse Large B-cell Lymphoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialDALY II USA/ MB-CART2019.1 for DLBCL
Shares Miltenyi Biomedicine, Zamtocabtagene autoleucel, Bendamustine, Diffuse large B-cell lymphoma.
- TrialDALY II Japan/MB-CART2019.1 for DLBCL
Shares Miltenyi Biomedicine, Zamtocabtagene autoleucel, Diffuse large B-cell lymphoma.
- TrialSafety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms
- TrialA Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcita
Shares CAPOX (capecitabine, oxaliplatin), Rituximab, Gemcitabine, Diffuse large B-cell lymphoma.
- TrialStudy to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lym
Shares CAPOX (capecitabine, oxaliplatin), Rituximab, Gemcitabine, Diffuse large B-cell lymphoma.
- TrialA Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Shares Bendamustine, Rituximab, Diffuse large B-cell lymphoma.
- TrialStudy of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Shares Rituximab, Gemcitabine, Diffuse large B-cell lymphoma.
- TrialA Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
Shares CAPOX (capecitabine, oxaliplatin), Gemcitabine, Diffuse large B-cell lymphoma.